CLINICAL_TRIALS
trial_result
· 2015-08-25
Clinical Trial Update: Gevokizumab for Active Scleritis [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of Gevokizumab for active scleritis has completed, and its results were posted in August 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Eye Institute (NEI) | Conditions: Scleritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-08-25